Clinical Development Asset Lead

Clinical Development Asset Lead

Position purpose

Adimanebart (ARGX-119) is a novel anti-MuSK (muscle-specific kinase) agonist monoclonal antibody being developed as a pipeline in a product for neuromuscular diseases. argenx is seeking a dynamic clinical development leader to provide expertise across multiple indications, including CMS (congenital myasthenic syndromes), ALS (amyotrophic lateral sclerosis), and SMA (spinal muscular atrophy) clinical programs, while also driving the rapid evaluation of new indications. The candidate will be responsible for delivering strategic clinical development leadership and oversight as part of the Asset Strategy Team (a cross-functional group focused on maximizing asset potential), working closely with other team members and the indication development teams to maximize the value of the asset and the success of the multi-indication program. The ideal candidate will have significant experience in clinical devel...